Esophageal Cancer PDX Models
Esophageal cancer is the 6th most common cause of cancer related deaths which drives a need for a better understanding of the underlying mechanisms behind the disease through preclinical models. Patient-derived xenograft (PDX) models provide a true representation of the human heterogeneity and can be used to better understand these mechanisms in relation to the development of new therapies. CrownBio has a large selection of well characterized esophageal cancer PDX models, including models with EGFR amplification. More